Financials
- Market Capitalization 20.6 M
- Employee 18
- Founded 2020
- CEO N/A
- Website www.tevogen.com
- Headquarter Delaware, United States
- FIGI BBG013395405
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.7
ratio cours/chiffre d'affaires
-66.55
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4583 | KZIA Kazia Therapeutics Limited - American Depositary Shares | 13.70 USD | +1.71% | +5.63% | -4.20% | +134.19% | 22.18 M USD | ||
| 4589 | SKYE Skye Bioscience, Inc. - Common Stock | 0.62 USD | 0.00% | -12.68% | -11.43% | -22.50% | 21.79 M USD | ||
| 4600 | CLRB Cellectar Biosciences, Inc. - Common Stock | 2.60 USD | -1.14% | -2.62% | +10.64% | -17.20% | 20.78 M USD | ||
| 4608 | ATOS Atossa Therapeutics, Inc. - Common Stock | 2.37 USD | +4.87% | -2.87% | +0.42% | +160.44% | 20.41 M USD |